Compare INGN & BWG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | INGN | BWG |
|---|---|---|
| Founded | 2001 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 163.7M | 142.4M |
| IPO Year | 2014 | N/A |
| Metric | INGN | BWG |
|---|---|---|
| Price | $5.89 | $8.50 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $11.00 | N/A |
| AVG Volume (30 Days) | ★ 199.6K | 53.8K |
| Earning Date | 02-24-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 11.37% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $347,028,000.00 | N/A |
| Revenue This Year | $8.04 | N/A |
| Revenue Next Year | $8.34 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 4.68 | N/A |
| 52 Week Low | $5.70 | $6.86 |
| 52 Week High | $12.91 | $8.65 |
| Indicator | INGN | BWG |
|---|---|---|
| Relative Strength Index (RSI) | 33.55 | 53.96 |
| Support Level | $6.11 | $8.42 |
| Resistance Level | $6.47 | $8.58 |
| Average True Range (ATR) | 0.29 | 0.09 |
| MACD | -0.06 | -0.00 |
| Stochastic Oscillator | 3.99 | 51.34 |
Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. Internationally, It sells its products through distributors large gas companies, and home oxygen providers. It generates the majority of its revenue in the United States.
BrandywineGLOBAL - Global Income Opportunities Fund Inc is a non-diversified, closed-end management investment company. The primary investment objective is to provide current income. The secondary investment objective is capital appreciation. The Fund seeks to achieve its investment objectives by investing, under normal market conditions, at least 80% of its assets in world-wide fixed-income securities.